Please Wait
Applying Filters...
menu
    • menu
    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    dmfs-not-supported-m-2025-05-19

    Virtual Booth

    An Enquiry

    Chirogate is a professional Prostaglandin manufacturer.

    Virtual Booth

    Contact Supplier

    Temad- We think of world-class quality.

    Virtual Booth

    Contact Supplier

    jdmfs-not-supported-m-2025-04-28

    Virtual Booth

    An Enquiry

    Menu

    Burixafor hydrobromide

    DEVELOPMENTS

    INTERMEDIATES

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Exicure Completes Patient Enrollment in Phase 2 Study of GPC-100
    Exicure Completes Patient Enrollment in Phase 2 Study of GPC-100

    05 May 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250505513656/en/Exicure-Completes-Patient-Enrollment-in-Phase-2-Study-of-GPC-100-for-Stem-Cell-Mobilization-in-Multiple-Myeloma-Patients-Undergoing-Autologous-Transplant

    BUSINESSWIRE
    05 May 2025
    Share Share
    PharmaVentures advises GPCR Therapeutics on their acquisition of Burixafor
    PharmaVentures advises GPCR Therapeutics on their acquisition of Burixafor

    24 Nov 2020

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/pharmaventures-advises-gpcr-therapeutics-on-their-acquisition-of-burixafor-301179049.html#:~:text=PharmaVentures%20advises%20GPCR%20Therapeutics%20on%20their%20acquisition%20of%20Burixafor,-News%20provided%20by&text=(GPCR)%20providing%20due%20diligence%20for,of%20Burixafor%20for%20worldwide%20markets.

    PRNEWSWIRE
    24 Nov 2020
    Share Share